Published “The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial” in Nature Medicine — cited 558 times.
- #crossref
- #research
- #work
Published “The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial” in Nature Medicine — cited 558 times.
Captured 2026-08-24 from Crossref. The archived copy is preserved so this citation survives link rot.